Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bidlack

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1996
Kappa Opioid receptors on immune cells as studied by fluorescent ligandsJ M Bidlack, D M Lawrence, T A Ignatowski
European Journal of Pharmacology|November 2, 1992
kappa-Opioid binding sites on a murine lymphoma cell lineJ M Bidlack, L D Saripalli, D M Lawrence
The Journal of Biological Chemistry|April 25, 1982
Purification of phospholamban, a 22,000-dalton protein from cardiac sarcoplasmic reticulum that is specifically phosphorylated by cyclic AMP-dependent protein kinaseJ M Bidlack, I S Ambudkar, A E Shamoo
Journal of Neurochemistry|June 1, 1988
Guanine nucleotide regulation of [125I]beta-endorphin binding to rat brain membranes: monovalent cation requirementD E Selley, C B Tyler, J M Bidlack
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonistsQ Jiang, A Sebastian, S Archer, et al.
Life Sciences|January 1, 1983
Generating monoclonal antibodies to the opioid receptorJ M Bidlack, R R Denton, L W Harwell
Biochemical Pharmacology|January 6, 1995
Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector couplingD M Lawrence, D B Joseph, J M Bidlack
European Journal of Pharmacology|January 5, 1993
5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone: a long-lasting mu-opioid receptor antagonist devoid of agonist propertiesQ Jiang, A Sebastian, S Archer, et al.
European Journal of Pharmacology|August 24, 1993
Antinociceptive evaluation of 14 beta-(bromoacetamido)-7,8-dihydro- N(cyclopropylmethyl)-normorphinone in miceQ Jiang, A Seyed-Mozaffari, S Archer, et al.
Journal of Medicinal Chemistry|May 27, 1994
14 alpha,14' beta-[Dithiobis[(2-oxo-2,1-ethanediyl)imino]]bis (7,8-dihydromorphinone) and 14 alpha,14' beta-[dithiobis[(2-oxo-2,1- ethanediyl)imino]]bis[7,8-dihydro-N-(cyclopropylmethyl)normorphinone]: chemistry and opioid binding propertiesS Archer, A Seyed-Mozaffari, Q Jiang, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Advances in Experimental Medicine and Biology|January 1, 1996
Kappa Opioid receptors on immune cells as studied by fluorescent ligandsJ M Bidlack, D M Lawrence, T A Ignatowski
European Journal of Pharmacology|November 2, 1992
kappa-Opioid binding sites on a murine lymphoma cell lineJ M Bidlack, L D Saripalli, D M Lawrence
The Journal of Biological Chemistry|April 25, 1982
Purification of phospholamban, a 22,000-dalton protein from cardiac sarcoplasmic reticulum that is specifically phosphorylated by cyclic AMP-dependent protein kinaseJ M Bidlack, I S Ambudkar, A E Shamoo
Journal of Neurochemistry|June 1, 1988
Guanine nucleotide regulation of [125I]beta-endorphin binding to rat brain membranes: monovalent cation requirementD E Selley, C B Tyler, J M Bidlack
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonistsQ Jiang, A Sebastian, S Archer, et al.
Life Sciences|January 1, 1983
Generating monoclonal antibodies to the opioid receptorJ M Bidlack, R R Denton, L W Harwell
Biochemical Pharmacology|January 6, 1995
Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector couplingD M Lawrence, D B Joseph, J M Bidlack
European Journal of Pharmacology|January 5, 1993
5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone: a long-lasting mu-opioid receptor antagonist devoid of agonist propertiesQ Jiang, A Sebastian, S Archer, et al.
European Journal of Pharmacology|August 24, 1993
Antinociceptive evaluation of 14 beta-(bromoacetamido)-7,8-dihydro- N(cyclopropylmethyl)-normorphinone in miceQ Jiang, A Seyed-Mozaffari, S Archer, et al.
Journal of Medicinal Chemistry|May 27, 1994
14 alpha,14' beta-[Dithiobis[(2-oxo-2,1-ethanediyl)imino]]bis (7,8-dihydromorphinone) and 14 alpha,14' beta-[dithiobis[(2-oxo-2,1- ethanediyl)imino]]bis[7,8-dihydro-N-(cyclopropylmethyl)normorphinone]: chemistry and opioid binding propertiesS Archer, A Seyed-Mozaffari, Q Jiang, et al.
Pageof 10